Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Nutr Metab Cardiovasc Dis ; 28(5): 510-516, 2018 05.
Article in English | MEDLINE | ID: mdl-29501443

ABSTRACT

BACKGROUND AND AIM: Serum calcium levels (sCa) were reported to be associated with cardiovascular risk factors, incidence of coronary artery disease and acute myocardial infarction (AMI). The current study evaluated the association between sCa and in-hospital mortality among AMI patients. METHODS AND RESULTS: Patients admitted in a tertiary medical center for AMI throughout 2002-2012 were analyzed. For each patient, mean sCa, corrected to albumin, was calculated and categorized to seven equally-sized groups: <8.9, 8.9-9.12, 9.12-9.3, 9.3-9.44, 9.44-9.62, 9.62-9.86, ≥9.86 mg/dL. The primary outcome was all-cause in-hospital mortality. Out of 12,121 AMI patients, 11,446 were included, mean age 67.1 ± 14 years, 68% Males. Mean number of sCa values for patient was 4.2 ± 7.3. Mean sCa was 9.4 ± 0.53 mg/dL, range 5.6-13.2 mg/dL sCa was significantly associated with cardiovascular risk-factors, in-hospital complications, more frequent 3-vessel coronary artery disease and decreased rate of revascularization, often in a U-shaped association. Overall 794 (6.9%) patients died in-hospital. Multivariate analysis showed a significant U-shaped association between sCa and in-hospital mortality with sCa below 9.12 mg/dL and above 9.86 mg/dL as independent predictors of significantly increased in-hospital mortality: OR = 2.4 (95% CI:1.7-3.3) and 1.7 (95%CI:1.2-2.4), for Ca<8.9 and Ca≥9.86 mg/dL respectively p < 0.01, as compared with middle rage sCa group (9.3-9.44 mg/dL). CONCLUSION: sCa is an independent predictor of in-hospital mortality in patients with AMI with a U-shaped association. Both increased and decreased sCa levels are associated with increased risk of in-hospital mortality.


Subject(s)
Calcium/blood , Hospital Mortality , Myocardial Infarction/blood , Myocardial Infarction/mortality , Patient Admission , Aged , Aged, 80 and over , Biomarkers/blood , Female , Humans , Israel/epidemiology , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/therapy , Predictive Value of Tests , Retrospective Studies , Risk Assessment , Risk Factors , Tertiary Care Centers , Time Factors
2.
Public Health ; 143: 25-36, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28159024

ABSTRACT

OBJECTIVES: We evaluated long-term survival after acute myocardial infarction (AMI) in unselected 'real life' patients according to the various risk groups, and it's persistence with time after AMI as compared with the matched general population. STUDY DESIGN: Retrospective study. METHODS: Data were collected from 2671 AMI hospital survivors (tertiary medical centre in Israel), which included demographics, clinical characteristics of AMI, comorbidities, interventions and test results. All-cause mortality during the 10-year follow-up period was compared with age-, sex- and ethnicity/religion-matched general population using standardized mortality ratios (SMRs). RESULTS: Overall mortality of AMI patients (48.6%) was higher than the general population (SMR, 2.2; P < 0.001). Mortality rates and SMRs tended to be greater in higher risk strata of patients, Jews vs Muslims, women vs men, non-ST-elevation acute myocardial infarction (NSTEMI) vs ST-elevation acute myocardial infarction (STEMI), non-invasive treatment vs invasive treatment, and recurrent vs first AMI. Mortality rates increased with age, but SMRs were highest in the youngest group. Through the follow-up period, SMR was highest during the first year after discharge (SMR, 4.85; P < 0.001) and higher in 7th-10th years compared with 2nd-6th years. CONCLUSION: Patients who survived hospital admission with AMI continue to be at higher (approximately twice) risk of death compared with the general population for at least 10-year follow-up period and especially throughout the first and 7th-10th years after AMI, young women, high-risk patients, Jews, NSTEMI, non-invasively treated and recurrent AMI. These findings can assist healthcare providers and decision makers prioritizing targets of secondary prevention and allocation of resources.


Subject(s)
Mortality/trends , Myocardial Infarction/therapy , Survivors/statistics & numerical data , Aged , Female , Hospitalization , Humans , Israel/epidemiology , Male , Middle Aged , Retrospective Studies , Time Factors
3.
Am J Cardiol ; 85(5): 559-62, 2000 Mar 01.
Article in English | MEDLINE | ID: mdl-11078267

ABSTRACT

The poor long-term outcome in young diabetic patients receiving stents is not well understood. The purpose of this study was to characterize the pastprocedural results of stent placement in diabetic patients using intravascular ultrasound to identify factors that might be associated with poor clinical outcome. The acute dimensions from intravascular ultrasound studies after stent deployment at 5 sites were measured from 39 coronary segments from patients with diabetes mellitus (DM) and 161 segments from nondiabetic patients (non-DM). Within these 2 groups, segments were subgrouped into young (y) and old (o) in reference to the mean study age of 64 years, forming 4 groups: yDM (n = 20), y non-DM (n = 65), oDM (n = 19), and o non-DM (n = 96). Results are reported as mean +/- 1 SD. Diabetic patients had smaller mean lumen area within the treated segment than o non-DM (8.37+/-2.59 vs. 9.11+/-3.35 mm2, p<0.01). These differences were more pronounced at the distal reference vessel lumen of yDM than y non-DM (7.6+/-2.3 vs. 10.3+/-4.5 mm2, p<0.003), and were associated with greater percent plaque area in the distal reference vessel (43.4+/-13% vs. 34.1+/-11.2%, p<0.003). In young diabetic patients undergoing elective stent placement, underexpansion of the stented segment is common, which may contribute to the relatively poor long-term outcome in these patients. We suggest that when stenting is the procedure of choice in this subgroup of high-risk patients, special attention should be given to optimizing lumen dimensions.


Subject(s)
Coronary Disease/diagnostic imaging , Coronary Vessels/diagnostic imaging , Diabetic Angiopathies/diagnostic imaging , Stents , Ultrasonography, Interventional , Age Factors , Aged , Cohort Studies , Coronary Disease/therapy , Diabetic Angiopathies/therapy , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , Treatment Outcome
4.
Am J Cardiol ; 86(11): 1281-4, A9, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11090812

ABSTRACT

In this prospective study, a significant incidence of fever (47%), true bacteremia (15%), and sepsis (12%), were found in 60 cardiac patients treated with an intra-aortic balloon counterpulsation pump. The benefit of antibiotic prophylaxis in this setting should therefore be evaluated.


Subject(s)
Bacteremia/epidemiology , Equipment Contamination , Heart Diseases/therapy , Intra-Aortic Balloon Pumping/adverse effects , Adult , Aged , Aged, 80 and over , Bacteremia/etiology , Female , Hospital Mortality , Humans , Incidence , Israel/epidemiology , Male , Middle Aged , Prospective Studies , Sepsis/epidemiology , Sepsis/etiology , Survival Rate
5.
Coron Artery Dis ; 12(4): 313-6, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11428540

ABSTRACT

This study investigates a strategy of low-pressure stenting with concomitant anti-platelet treatment designed to prevent short- and long-term events after stenting. Ninety consecutive patients who underwent percutaneous transluminal coronary angioplasty with stenting using low-pressure stent deployment (mean 8.1 atmospheres) with concomitant anti-platelet therapy based on ticlopidine and aspirin were followed. The 30-day outcome revealed a stent thrombosis rate of 6.4%, while the 9-month major clinical event rate was 8.6%. Low-pressure stent deployment appears to confer added risk for acute or sub-acute thrombosis even when aspirin and ticlopidine are used. Conversely, low-pressure inflation is associated with excellent long-term results.


Subject(s)
Angioplasty, Balloon, Coronary , Coronary Artery Disease/therapy , Platelet Aggregation Inhibitors/therapeutic use , Stents , Aged , Combined Modality Therapy , Coronary Artery Disease/complications , Coronary Artery Disease/diagnostic imaging , Equipment Design , Humans , Male , Middle Aged , Pressure , Radiography , Retrospective Studies , Stents/adverse effects , Treatment Outcome
6.
Int J Cardiol ; 33(1): 162-5, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1937972

ABSTRACT

Dual connection of the left anterior descending coronary artery to the left and right coronary arteries is a very rare congenital anomaly. In this report we describe two cases in which the mid-position of the left anterior descending coronary artery is connected to the right coronary artery, one directly and the second by way of the infundibular artery. To the best of our knowledge, connection of the mid-position of the left anterior descending to the infundibular artery has not been previously described.


Subject(s)
Coronary Vessel Anomalies/diagnostic imaging , Adult , Coronary Angiography , Coronary Vessel Anomalies/epidemiology , Humans , Male , Middle Aged
7.
Int J Cardiol ; 45(2): 135-7, 1994 Jun 15.
Article in English | MEDLINE | ID: mdl-7960252

ABSTRACT

A left main aneurysm is a rare angiographic finding. We describe a 59-year-old male with a large aneurysm in the left main coronary artery. The aneurysm had enlarged in comparison to its diameter of 3.5 years previously, together with a progression of severity of his coronary stenoses.


Subject(s)
Coronary Aneurysm/diagnostic imaging , Myocardial Infarction/diagnostic imaging , Angina Pectoris/diagnostic imaging , Coronary Angiography , Follow-Up Studies , Humans , Male , Middle Aged
8.
Angiology ; 47(3): 281-4, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8638872

ABSTRACT

Streptokinase is the mainstream therapy for acute myocardial infarction. A fifty-seven-year-old man with acute MI was admitted to the intensive cardiac care unit and received streptokinase and heparin. At the time of admission, he was not receiving any drugs and denied any previous exposure to a hepatotoxic agent. Five hours later he developed a dramatic hypersensitivity reaction including high fever, pulmonary edema, cyanosis, and convulsions. Within twelve hours, his clinical state was stabilized. After forty-eight hours, he developed jaundice and transaminasemia, which subsided by the eighth day. Only a few reports of overt jaundice are associated with streptokinase.


Subject(s)
Fibrinolytic Agents/adverse effects , Jaundice/chemically induced , Streptokinase/adverse effects , Anticoagulants/therapeutic use , Cyanosis/chemically induced , Drug Hypersensitivity/etiology , Fever/chemically induced , Heparin/therapeutic use , Humans , Male , Middle Aged , Myocardial Infarction/drug therapy , Pulmonary Edema/chemically induced , Seizures/chemically induced , Thrombolytic Therapy/adverse effects , Transaminases/blood
10.
Angiology ; 43(7): 572-7, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1626735

ABSTRACT

Streptokinase is well established as an effective thrombolytic. Anistreplase, a new thrombolytic drug, is a complex of streptokinase and acylated human plasminogen that can be administered by intravenous bolus and activates plasminogen at the clot site. Although both streptokinase and anistreplase are effected in treating myocardial infarction (MI), they have different pharmacologic properties. This study was designed to identify short- and long-term differences in their clinical effectiveness, safety in use, and survival rates in patients with acute MI. One hundred ten successive patients under seventy years of age admitted within three hours after onset of sustained chest pain suggestive of acute MI were randomized to receive either 30 units of anistreplase intravenously over five minutes or intravenous injection of 750,000 units of streptokinase over thirty to sixty minutes. Reperfusion was achieved in 34 of the 52 (65%) patients treated with anistreplase and in 41 of the 58 (71%) patients treated with streptokinase (p = NS). The two drugs were equally effective in preserving left ventricular ejection fraction, which was found to be significantly better in patients with anterior wall MI who had achieved reperfusion than it was in those who did not (p less than 0.02). One-month, twelve-month, and thirty-six-month survival rates were high (96% to 88%) with no significant difference between the two treatment groups. The authors conclude that the two drugs are equally effective thrombolytic agents but that anistreplase has the advantage that it can be administered as a bolus injection.


Subject(s)
Anistreplase/therapeutic use , Myocardial Infarction/drug therapy , Streptokinase/therapeutic use , Thrombolytic Therapy , Aged , Anistreplase/adverse effects , Female , Humans , Male , Middle Aged , Myocardial Infarction/mortality , Myocardial Infarction/physiopathology , Myocardial Reperfusion , Streptokinase/adverse effects , Stroke Volume , Thrombolytic Therapy/adverse effects
11.
Harefuah ; 136(10): 777-9, 843, 1999 May 16.
Article in Hebrew | MEDLINE | ID: mdl-10955111

ABSTRACT

The most common invasive procedure performed in hospitals is the insertion of a vascular access device. This procedure has the rare complication of catheter emboli. Accidental cutting of a peripheral catheter, the use of duplex ultrasound to locate the cut and the extraction of the catheter through a venesection is described. If peripheral extraction fails, percutaneous extraction or thoracotomy should be tried, in that order. The immediate precautions have an impact on the final results.


Subject(s)
Catheterization, Peripheral , Catheters, Indwelling , Equipment Failure , Foreign Bodies/surgery , Ultrasonography, Doppler, Duplex , Aged , Humans , Male
12.
Harefuah ; 121(10): 369-73, 1991 Nov 15.
Article in Hebrew | MEDLINE | ID: mdl-1752552

ABSTRACT

Since the resting blood pressure (BP) does not predict round-the-clock values, in order to evaluate the disease and its response to treatment BP should be measured during exertion. Verapamil, either 120 mg or 160 mg, twice daily, was given to 60 hypertensives at rest and during isometric effort, according to our previously reported protocol. There was a significant response (p less than 0.005) to the treatments. Sustained release verapamil, 240 mg once a day, reduced systolic and diastolic BP significantly in 38 of 45 hypertensives at rest and during isometric effort. A simple, inexpensive, cost-effective, hand-grip method is strongly recommended as an integral part of treatment evaluation. The combination of highly effective drugs together with a simple method of BP evaluation may result in improved long-term treatment.


Subject(s)
Exercise Test/methods , Hypertension/drug therapy , Verapamil/therapeutic use , Blood Pressure/drug effects , Delayed-Action Preparations , Evaluation Studies as Topic , Humans , Hypertension/physiopathology , Verapamil/administration & dosage , Verapamil/pharmacology
13.
Harefuah ; 126(10): 570-3, 628, 1994 May 15.
Article in Hebrew | MEDLINE | ID: mdl-8034243

ABSTRACT

The practice of primary medicine within a military framework differs from that in the civilian environment in: accessibility, its consumers, obligations of the providers, involvement of the funder (the commanders), and ability to define and enforce professional guide lines. These differences influence the scope of medical service, as well as affect the methods and results of quality control. A system of quality control evaluation and feedback of military primary care in 16 Israel Air Force clinics was carried out by a team of experienced physicians using peer group review and according to a specially prepared protocol. Emphasis was placed on medical record assessment using obligatory markers of adequate medical evaluation and treatment. Identification of the population at risk, further medical training, and medical administration with a direct effect on the quality of medical treatment were also evaluated. 2 quality control surveys with feedback were carried out 6 months apart. The overall mean score was 81.66 +/- 7.16% at the first evaluation, increasing to 88.60 +/- 7.46% at the second (p < 0.01). The greatest improvements were in follow-up of population at risk (increasing from 68.4% to 86.4%, p < 0.025), training of medical teams, (from 75.7% to 87.5%, p < 0.05) and patient case management (from 79.4% to 85.1%, N.S.). Categories in which there was no improvement were medical records, recovery of old medical files and patient education. The categories in which there was improvement had a common denominator: "recognition of importance" and "provision of patterns" by headquarters. The quality control system was designed for routine use, and not as a research project.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Aerospace Medicine/standards , Outpatient Clinics, Hospital/standards , Primary Health Care/standards , Quality Assurance, Health Care , Humans , Israel , Medical Audit , Quality Control
17.
Platelets ; 6(6): 371-6, 1995.
Article in English | MEDLINE | ID: mdl-21043767

ABSTRACT

Hepoxilin-A(3) (Hx-A(3)) is produced by platelets in response to shear-stress. It has an antithrombotic effect on platelets. A low Hx-A(3) level may contribute to the high thrombogenic state that exists in patients with acute coronary syndromes. Since we have previously demonstrated that the regulatory volume decrease (RVD) of human platelets exposed to hypotonic solutions is controlled by Hx-A(3) it is possible that the RVD rate reflects Hx-A(3) activity. In this study, the RVD rate of platelets taken from a healthy control group (n=21) was compared to that of patients with chronic ischemic heart disease (n=23), acute ischemic heart disease (n = 24) and acute myocardial infarction (MI, n = 29). The RVD rate of the control group was significantly higher than the other three groups (P < 0.001). The addition of 100 nM of Hx-A, to the platelets of eight patients with MI increased their RVD rate to that of the controls. Patients with diabetes mellitus or hypertension have the lowest RVD rates. Medications such as aspirin, heparin, and streptokinase did not affect the Hx-A(3) activity of platelets obtained from patients with ischemic heart disease. The results of the present study indicate that patients with acute ischemia may have a low level of platelet Hx-A(3) activity. This possible low level of Hx-A, activity may be associated with a failure to develop an antithrombotic reaction to the shear-stress forces generated during acute ischemia.

18.
S Afr Med J ; 83(11): 840-2, 1993 Nov.
Article in English | MEDLINE | ID: mdl-7839216

ABSTRACT

Blood pressure at rest is not predictive of round-the-clock values. Blood pressure should therefore be measured during effort to evaluate hypertension and its response to treatment. The effect of sustained-release verapamil (240 mg taken once a day) on blood pressure at rest and during isometric effort was therefore investigated. Overall, verapamil reduced blood pressure significantly in 41 of 45 hypertensive patients: the mean systolic blood pressure at rest (+/- SD) fell from 151 +/- 35 mmHg to 137 +/- 13 mmHg (P < 0.001) and the diastolic blood pressure from 97 +/- 21 mmHg to 83 +/- 7 mmHg (P < 0.001), while the systolic blood pressure during isometric effort fell from 186 +/- 23 mmHg to 156 +/- 13 mmHg (P < 0.001) and the diastolic blood pressure from 118 +/- 14 mmHg to 95 +/- 8 mmHg (P < 0.001). The simple, inexpensive handgrip method described is cost-effective and strongly recommended as an integral part of the evaluation of hypertensive patients. The combination of a drug to which compliance is good and a simple method of blood pressure evaluation should result in improved effectiveness of treatment in the long term.


Subject(s)
Ergometry/methods , Hypertension/prevention & control , Verapamil/administration & dosage , Adult , Blood Pressure/drug effects , Delayed-Action Preparations , Female , Humans , Hypertension/diagnosis , Isometric Contraction , Male , Middle Aged
19.
Catheter Cardiovasc Interv ; 50(2): 212-4, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10842393

ABSTRACT

We describe a patient in whom balloon rupture occurred three times during inflation in a stent with restenosis in the left anterior descending artery. The cause of rupture was detected by intravascular ultrasound: a calcified ridge that protruded between the stent struts in the distal stent body.


Subject(s)
Angina, Unstable/therapy , Angioplasty, Balloon, Coronary/adverse effects , Calcinosis/diagnostic imaging , Cardiomyopathies/diagnostic imaging , Stents , Ultrasonography, Interventional , Aged , Female , Humans , Treatment Failure
20.
Cathet Cardiovasc Diagn ; 20(3): 200-1, 1990 Jul.
Article in English | MEDLINE | ID: mdl-2364420

ABSTRACT

We describe a patient with an unusual coronary anatomic variant in which the obtuse marginal gives rise to the posterior descending artery. The angiographic features and clinical recognition of this anomaly are reviewed.


Subject(s)
Coronary Vessel Anomalies/diagnostic imaging , Aged , Angiography , Coronary Angiography , Humans
SELECTION OF CITATIONS
SEARCH DETAIL